The R08-4B6 recombinant monoclonal antibody has been genetically engineered to specifically target human MAPKAPK3. It is suitable for use in a variety of assays, including WB, IP. This MAPKAP kinase 3 antibody was used in western blot analysis of MK3 in A549, HL-60 lysates.
Figure 1 Anti-MAPKAPK3 Antibody (VS3-FY2036) in WB.
The MK3 expression in A549, HL-60 lysates were detected using the anti-MAPKAP Kinase 3 by western blot assay.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1202CT | Recombinant Mouse anti-Human MAPKAPK3 Monoclonal antibody (EML2251) | WB |
There are currently no Customer reviews or questions for VS3-FY2036. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.